International Journal of Technology Assessment in Health Care

Papers
(The median citation count of International Journal of Technology Assessment in Health Care is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
A collaborative pilot on current awareness alerts for disinvestment and horizon scanning130
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders – Erratum27
OP123 The Use Of Surrogate Outcomes In National Institute For Health And Care Excellence (NICE) Highly Specialised Technology Evaluations: A Review Of Published Guidance25
Using INTEGRATE-HTA for the assessment of videorasterstereography in idiopathic scoliosis25
PP428 Rechargeable Versus Recharge-Free Sacral Neurostimulation: An Australian Health Economics Analysis21
PP296 Patient Involvement In An Assessment Of The Management Of Sudden Onset Severe Headache Presenting To The Emergency Department20
PP254 Double-Counting In Evidence Synthesis Including Routinely Collected Data: Methodological and Practical Considerations19
PP89 The Investigation And Development Of A National Formulary Monitoring System Across Wales15
PP230 Safety, Effectiveness, And Cost Effectiveness Of Interventions For Preventing Delirium In Hospitalized Patients15
PP403 New Medical Technology Adoption In Asia Pacific: Focused On South Korea And Japan14
PP451 Does NICE Reimburse Oncology Treatments Meeting End-Of-Life Criteria More Often Than Treatments That Do Not?14
PP231 Safety, Effectiveness And Economic Analysis Of Exercise Intervention For Prevention Of Cognitive And Functional Deterioration In Hospitalized Patients14
PP94 Pandemic Preparedness: EUnetHTA COVID-19 Rapid Response With “Rolling Collaborative Reviews (RCR)”13
PP447 Informing The Development And Evaluation Of An Evidence-Based Service Delivery Model For Mental Health Patients With Complex Needs13
OP318 Health Technology Assessment And Decision-Making Processes: The Purchase Of Magnetic Resonance Imaging Technology13
OP312 Developing A Tool-kit For Assessment Of Autism Spectrum Disorder13
PP106 Twenty Years Of Orphan Medicines Regulation: Have Treatments Reached Patients In Need Across Europe And Canada?13
PP299 A Framework And Analysis Assessing The Impact Of Patient-Centered Outcome Evidence In HTA Appraisals13
PP216 Indirect Treatment Comparison Assessment: An Improvement Intervention In The Scottish Medicines Consortium12
The transcatheter aortic valve implantation: an assessment of the generalizability of the economic evidences following a systematic review10
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities – Erratum10
Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations10
Deliberative processes in decision making informed by health technology assessment in Latin America10
The contribution of French patient and consumer groups to health technology assessments over a 2-year period: an observational retrospective study10
Information specialist collaboration in Europe: Collaborative methods, processes and infrastructure through EUnetHTA—CORRIGENDUM10
Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 39
Methods and criteria for the assessment of orphan drugs: a scoping review9
Addressing uncertainty in relative effectiveness assessments by HTA organizations9
Technology assessment framework for precision health applications9
Pilot approach to analyzing patient and citizen involvement in health technology assessment in four diverse low- and middle-income countries9
Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations8
PP83 Economic Impact Of Missed Vaccinations On The Italian National Health System8
Moving from intervention management to disease management: a qualitative study exploring a systems approach to health technology assessment in Canada8
OP49 A Systematic Review Of The Activities Of Early Advice, Early Dialogue, Scientific Advice By HTA Doers7
PP72 SARS-CoV-2: A Rapid Review On The Effectiveness Of Face Coverings To Reduce Transmission7
OP60 Methodological Guidance And Doctrine Of The French National Authority For Health For Economic Evaluation7
OP05 The Role Of Conditional Reimbursement In The Lifecycle Approach7
OP42 Increasing Access To Real-World Data To Move From Health Technology Assessment To Health Technology Management7
PP21 Efficacy And Safety Of Aromatherapy: An Overview Of Systematic Reviews7
Mind the evidence gap: the use of patient-based evidence to create “complete HTA” in the twenty-first century7
PP47 Modelling Non-small Cell Lung Cancer Treatment: Predicted and Observed Impact Of Immunotherapy In The Netherlands7
OP37 Lifecycle Evaluation Models And Frameworks Used To Assess Medical Devices: A Qualitative Evidence Synthesis7
PD09 Comparing Long-term Costs Associated With Intraocular Lens Selection And Nd:YAG Laser Capsulotomy In The UK: A Cost-Consequence Analysis7
PP97 Recommendations For Generating South African Health-Related Quality Of Life Data For Cost-Utility Analyses7
OP107 Streamlining Health Technology Assessment Of Medical Devices Through Development Of The Philippine Essential Medical Device List7
PP107 Scale For Measuring Fatigue In Patients With Parkinson’s Disease: Scientific Technical Report7
PP49 Financing The Line Of Care In The First Biochemical Relapse Of Prostate Cancer After [68Ga] PSMA PET- CT6
OP71 PriTec Tool 2: Adaptation For Selection Of Technologies To Be Assessed For Inclusion Into The Health Care System6
PP128 Development And Piloting Of An Online Training Course On Health Technology Assessment For Patients6
PP32 Assessment Of Preferences For Treatment: A Discrete Choice Experiment Among Italian Patients With Prostate Cancer6
PP53 Applying The VALIDATE Approach To Frame The Assessment Of Integrated Care Management In Aortic Valve Stenosis6
PD35 Mortality And Risk Factors Associated With Dialysis Patients With COVID-19 In A Brazilian Supplementary Health Service5
THC volume 38 issue S1 Cover and Front matter5
OP92 Impact Of Real-World Evidence On Health Technology Assessment And National Guidance For Interventional Procedures: A UK Perspective5
OP46 Assessing The Quality Of Pharmacoeconomic Evaluations About Type 2 Diabetes Mellitus Drugs In National Reimbursement Drug List5
OP06 Percutaneous Transforaminal Endoscopic Discectomy: From Insufficient Evidence To Reimbursement5
PP91 Developing A Re-assessment Process For Non-medicine Health Technologies In Wales4
PD44 Realistic Review: Theoretical Model For Monitoring And Evaluation (M&E) Of Health Technology Assessment Management4
PP150 The Role Of Expert Consensus In UK Guidance: Patient Selection For Hydrogel Spacer Use During Prostate Cancer Radiotherapy4
PP81 Barriers To Implementation Of Health Technology Assessment4
PP140 Economic Evaluation Of Several Vaccination Strategies Against Rotavirus In Spain4
OP84 Cost Consequence Analysis: A Potential Framework To Incorporate Patient Preferences Into Health Technology Assessment And Reimbursement Decisions4
PP48 A Micro-Costing Study For Circulating Tumor DNA testing In Oncology4
OP80 ‘Green Metrics’ - Incorporating Environmental Dimensions In Health Technology Assessment4
PP10 Impact Of COVID-19 On The Management Of Breast Cancer In Italy: The Perspectives Of Patients And Coordinators4
PP114 The Influence Of Implicit Factors On The Health Technology Assessment Deliberative Process: A Survey In Five European Countries4
OP20 Is The Quality Of Evidence In Health Technology Assessment Deteriorating Over Time?: A Case Study On Cancer Drugs In Australia4
PD03 Uptake Of Health Technology Assessment In Hospitals: A Scoping Review4
PP77 Safety, Effectiveness, And Cost Effectiveness Of Telemedicine In Neurological Diseases4
OP74 Assessing Public Confidence Towards COVID-19 Vaccines Through Social Media Insights Leveraged Using Artificial Intelligence Techniques4
OP15 Improving The Osteoporosis Care Trajectory By Collaboration Between Clinicians, Patients And Health Insurers Within the Appropriate Care Program4
PD12 Quality Assessment Of Health Economic Evaluation On Screening Programs From China4
PP71 Lessons Learned During Analyses Of Appropriate Hearing Care: Building Bridges Between Patient Organizations, Health Professionals And Insurance Companies4
Early technology review: towards an expedited pathway3
PP122 The Feasibility Assessment For Domestic Introduction Of Newborn Pulse Oximetry Screening For Critical Congenital Heart Disease3
PP71 Hospitalization Costs Associated With Advanced Non-Small Cell Lung Cancer In China: Real World Evidence From Jiangsu3
OP12 Post-Launch Evidence Generation Among Health Technology Assessment Bodies In Europe3
OP128 Uncertainties In The Cost-Effectiveness Analysis Of Onasemnogene Abeparvovec For Spinal Muscular Atrophy Type 13
OP88 Drawing Lines In The Sand: How Do We Define The Scope Of Analysis In HTA And Economic Evaluation?3
PP14 The Role Of Health Technology Assessment In The Public Hospitals Of The National Health Service Of Catalonia3
PP85 The Cost-Effectiveness Of The Anti-COVID Vaccination Campaign In The Italian Healthcare Setting3
PD38 Telehealth Use To Fight The COVID-19 Pandemic In A Brazilian Private Healthcare System3
Medicine characteristics affecting the time to guidance publication by National Institute for Health and Care Excellence in the single technology appraisal process3
Evidence-Informed Update of Argentina’s Health Benefit Package: Application of a Rapid Review Methodology3
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”3
PP26 Critical Review Of The Reimbursement Process For Software As A Medical Device And Challenges In South Korea3
PP138 Awareness Of Health Technology Assessment And Its Predictors Among Medical Students In Public Universities In Klang Valley, Malaysia3
PP37 A Systematic Review of Machine Learning and Statistical Models For Predicting Coronary Heart Disease In Diabetic Patients3
OP82 Positron Emission Tomography Combined With Computed Tomography Using 18F-Sodium Fluoride3
PP69 Supporting Decision Making: A Health Technology Assessment Training Proposal for Decision Makers3
PD34 Neuron-specific Biomarkers Associated With Neurological Manifestations In COVID-19: An Evidence Mapping Systematic Review3
Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health3
PP127 Early Health Technology Assessment (HTA) Of Medical Technologies To Inform Subsidy Decision-making In Singapore3
PD48 Does Unmet Need Influence The Scottish Medicines Consortium Health Technology Assessment Decisions For Rare Disease Conditions?3
OP79 Gene Expression Profiling In The Diagnosis Of Aggressive Large B Cell Lymphoma: An Early Exploratory Economic Evaluation3
PP41 Using Medicare Claims Data To Support Reimbursement Of A Novel Leadless Pacing System For The Management Of Bradycardia3
THC volume 38 issue S1 Cover and Back matter3
Can knowledgeable experts assess costs and outcomes as if they were ignorant? An experiment within precision medicine evaluation3
PP23 Lost In Translation? The Differences In The Use Of Real-World Evidence Across Key Markets3
PP146 The Use Of Indirect Comparisons For Reimbursement Decision Making In The Netherlands And England3
PP52 Will Joint European Health Technology Assessment Provide Additional Benefits Over Individual Country-wise Assessments?2
PP38 Immersion in water during childbirth: A survey to the Spanish National Health System2
OP149 How To Improve The Impact Of Health Technology Assessment: Stakeholders’ Perspectives In Spain2
OP52 Treating Osteoporosis In Postmenopausal Women With Denosumab (Prolia®): A Systematic Review And Network Meta-Analysis2
OP115 Scoping Meta-Review On Methods Used To Assess Artificial Intelligence-Based Medical Devices For Heart Failure2
OP130 Estimating The Economic Burden Of HIV/AIDS In Türkiye Towards The Next Decade2
PP90 Artificial Intelligence To Detect Ischemic Heart Disease In Non-traumatic Chest Pain At The Emergency Department – SmartHeart Study2
PP99 Positron Emission Tomography Combined With Computed Tomography (PET/CT) Using 11-C Methionine (11C-MET)2
PP97 How Health Technology Agencies Estimate Target Population Size For Medical Devices: The Example Of Spinal Cord Stimulation2
OP90 Multiple Myeloma: Developing A Benchmark Patient Experience Index In Australia And New Zealand2
PP49 Cost Of Cardiac Implantable Electronic Device (CIED) Infections In Australia: A Private And Public Sector Payer Perspective2
OP127 The Cost Effectiveness Of Anti-Vascular Endothelial Growth Factor Treatments For Age-Related Macular Degeneration In The Italian Healthcare Setting2
OP93 The Cost Effectiveness Of Antiretroviral Therapy Adherence Interventions In HIV/AIDS Patients: A Systematic Review Of Decision Analytic Models2
Development, testing, and implementation of a new procedure to assess the clinical added benefit of pharmaceuticals2
PP38 Designing A Training And Capacity Building Pathway In Patient Involvement2
OP94 Economic Evidence On Hemodialysis Access Creation Procedures In Patients With End-Stage Kidney Disease: A Systematic Literature Review2
OP07 Eleven Years Of Conitec: Advances And Challenges Of Patient And Public Involvement In The Brazilian Health Technology Assessment Process2
PP79 Publication Trends Of Network Meta-analyses In Europe And Asia: A Focus On Cardiovascular Disease2
OP100 Patient Perspectives In Value Assessment Frameworks: The Asia Pacific Perspective2
PP13 Results Of An International Survey About Barriers In Patient Involvement In Health Technology Assessment Of Digital Health Technologies2
PP124 Patisiran For Patients With Hereditary Transthyretin Amyloidosis (hATTR) With Stage 2 Polyneuropathy Or Who Have An Inadequate Response To Tafamidis2
OP01 Causal Association Between Type 2 Diabetes Mellitus And Risk Of Cancer2
Acknowledgements2
OP70 Treating Patients With Hormone-Sensitive Cancer On Endocrine Therapy With Denosumab (Prolia®): A Systematic Review And Network Meta-Analysis2
PP11 Patient Involvement In Drug Evaluations To Inform Funding Decisions: A Singapore Case Study2
OP14 Cost-Utility Analysis Of Regorafenib For Patients With Hepatocellular Carcinoma Who Progressed On Sorafenib Treatment2
OP19 Exploring The Environment/Capacity Of South African Citizen Actors To Contribute To Health Technology Assessment Processes, Policy Development And Institutionalization2
In Memoriam: H. David Banta2
PP50 Early Diagnosis Effect Of Newborns With Critical Congenital Heart Disease Using National Health Insurance Data In South Korea2
PP103 Budget Impact Analysis Of Utilization Of WavelinQ Endo-arteriovenous Fistula System For Hemodialysis Patients: An Australian Hospital Perspective2
OP08 International Benchmarking Of Health Technology Assessment Training Tools And Materials For Patients And Consumers2
OP171 Canadian Disease Registry Inventory: Environmental Scan Of The Literature2
OP165 Changing Decision Criteria: An Analysis Of Health Technology Assessment Reports To The Brazilian Unified Health System2
PP55 Citizens’ General Needs Assessment In SOTERIA Project: ‘User-friendly Digital Secured Personal Data And Privacy Platform’2
PP105 Efficacy, Effectiveness And Safety Of Letermovir For Prophylaxis Of Cytomegalovirus Infection And Disease Post-Allogeneic Hematopoietic Stem Cell Transplantation2
Proposing a health-specific organizational impact framework to evaluate organizational impacts in health technology assessments1
OP196 Clinical Decision Support Systems (CDSS) For Antibiotic Management: Factors Limiting Sustainable Digital Transformation1
Promoting health economic evaluation studies in the AYUSH system of medicine: the need of the hour1
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect1
Impact of indication changes on scoping for European Union Joint Clinical Assessment: scale of the problem and how to address it1
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review1
Adherence to country-specific guidelines among economic evaluations undertaken in three high-income and middle-income countries: a systematic review1
Dynamic HTA for digital health solutions: opportunities and challenges for patient-centered evaluation1
Case studies of health economic analyses informing pharmaceutical health technology assessments for essential medicine selection and public-sector guidelines in South Africa1
Effectiveness and safety of caplacizumab in acquired thrombotic thrombocytopenic purpura: health technology assessment and classification according to the methodology established in Colombia1
Establishment and implementation of hospital-based health technology assessment at King Hussein Cancer Center: can our model be an example?1
Emerging healthcare interventions: Patient-Centered Outcomes Research Institute’s programmatic initiative – CORRIGENDUM1
OP87 Value From A Multi-stakeholder Perspective: A Framework To Assess Digital Health Solutions For Improving Chronic Disease Management1
Links between accuracy and effectiveness of laboratory medicine equipment: use of the EUnetHTA core model to compare two analyzers by measuring HbA1c1
Disinvestment in healthcare: a scoping review of systematic reviews1
Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review1
Stakeholders’ perspectives on disinvestment of low-value healthcare interventions and practices in Malaysia: an online survey1
Food for thought: more explicit guidance for inclusion of caregiver perspectives in health technology assessment1
PP118 Cyclic Mental Health Technology Assessment with Priority Setting And Involving Stakeholders - A Case Report From The Netherlands1
On the role of cost-effectiveness thresholds in healthcare priority setting1
OP103 Enhancing Legitimacy And Coherent Value Appraisal Across Interventions In Healthcare And Social Services: Strategy Of The Québec Agency1
Health Technology Assessment in Support of National Health Insurance in South Africa1
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities1
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases1
Using social media research in health technology assessment: stakeholder perspectives and scoping review1
Patient preferences do matter: a discrete choice experiment conducted with breast cancer patients in six European countries, with latent class analysis1
A model-based study to estimate the health and economic impact of health technology assessment in Thailand1
Evidence of clinical benefit of cancer medicines considered for funding in Australia1
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis1
A voice to be heard: patient and public involvement in health technology assessment and clinical practice guidelines in Malaysia1
Assessing progression of health technology assessment implementation in Asia: a balanced scorecard for cross comparison of selected countries in Asia1
New challenges and solutions for information retrieval: information specialists as “bricklayers” in the health technology assessment framework1
An evaluation of managed access agreements in England based on stakeholder experience1
Ethics information retrieval in HTA: state of current practice1
Patient-reported outcomes using a wearable cardioverter-defibrillator: results from a systematic review1
Stakeholder preferences for attributes of digital health technologies to consider in health service funding1
HTA capacity building in Asia: towards one goal1
Designing collaborations involving health technology assessment: discussions and recommendations from the 2024 health technology assessment international global policy forum1
OP50 Health Equity Considerations In HTA: A Case Example Of Prenatal Screening1
Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future1
Acknowledgements1
A decision-support tool for funding health innovations at a tertiary academic medical center1
OP21 A Critical Review Of Existing Health Inequality And Health Inequity Frameworks In Evidence Synthesis1
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies1
Hospital-based health technology assessment of a screening rapid test MTBI (GFAP and UCH-L1 blood biomarkers) for mild traumatic brain injury1
Development of an international template to support patient submissions in Health Technology Assessments1
PP08 Evaluation Of Nutritional Status In Diabetic And Non-Diabetic Chronic Kidney Disease Patients Using A Web Tool1
Model for ASsessing the value of Artificial Intelligence in medical imaging (MAS-AI)1
Disruptive technologies in health care disenchanted: a systematic review of concepts and examples1
“What’s Keeping Me Up at Night?” Reflections on the COVID-19 Pandemic in Asia1
Mapping frameworks for synthesizing qualitative evidence in health technology assessment1
An operationalization framework for lifecycle health technology assessment: a Health Technology Assessment International Global Policy Forum Task Force report1
PD26 Overscreening For Older Women In Cervical And Breast Cancer Screening In Japan1
Scottish Health Technologies Group: enhancing patient engagement1
PP28 Is My Medicine Suitable For An Outcomes Based Agreement? The Feasibility Conundrum1
Multiple criteria decision analysis for medicine reimbursement in the Lebanese context1
Using discrete-choice experiments to elicit preferences for digital wearable health technology for self-management of chronic kidney disease1
Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia1
EUnetHTA’s contribution to the new legal framework for health technology assessment cooperation in Europe1
The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies1
A Technical Review of the ISPOR Presentations Database Identified Issues in the Search Interface and Areas for Future Development1
Stakeholder perspectives on the current status and potential barriers of patient involvement in health technology assessment (HTA) across Europe1
OP99 Participatory Approaches Used In Research And Development Of Medical Devices: A Comparison Of Focus groups, Interviews And Surveys1
Health technology assessment and innovation: here to help or hinder?1
OP90 Optimizing Health Technology Assessment And Appraisal For Orphan Drug Reimbursement: Experiences And Tools For Improvement1
Health technology assessment in traditional and complementary medicine: a scoping review of international activity and examples of acupuncture1
PP35 Defecography (Evacuation Proctography) For The Evaluation Of Pelvic Floor Disorders: A Literature Review1
Determinants of Managed Entry Agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countries1
PP147 Conditional Reimbursement Of Medicinal Products, A Procedure For Orphan Drugs, Conditionals and Exceptionals1
OP01 Convergent Validity Between Discrete Choice Experiment And Other Stated Preference Methods: A Multistudy Comparison1
PP42 Impact Of The COVID-19 Pandemic On Scottish Medicine Consortium Submission Characteristics, Acceptance Rates, And Time To Advice0
PD54 Burden Of Disease And Risk Factors Among Children Under 5 Years In China From 1990 To 20190
PP17 Is the PriTec Tool Useful In The Identification Of Disruptive Healthcare Technologies?0
PP22 A Lifecycle Approach To The Use Of Real-World Evidence In HTA Submissions And Resubmissions: A Decade’s Experience0
PP117 Larger Impact Of An Appropriate Care Program By Involving Healthcare Professionals: A Case Report On Cervical Pre-malignancy0
PP90 Effectiveness Of Music Therapy For Autism Spectrum Disorder, Dementia, Depression, Insomnia, And Schizophrenia0
OP97 Stakeholders’ Involvement In Brazilian Health Technology Assessment Incorporation In 2021: A Statistical Description Of Demands To The Brazilian National Committee For Health Technology Incorpora0
PP110 An External Combined Occipital And Trigeminal Neurostimulation Device For Migraine Treatment0
OP114 Health Technology Assessment Of Digital Technologies: Results From Two Past Examples And Thoughts For The Future0
PP89 Stimulating And Assuring Evidence Quality From A Dutch Funders’ Perspective – Introducing The ZonMw Reporting Checklist0
OP153 Access To Real-World Data For Use In Health Technology Assessment – Still Work To Be Done0
OP34 Horizon Scanning A Matter Of Collaboration. A Description Of The Processes Of I-HTS Member Organizations0
OP67 Considerations Of Treatment Novelty In Health Technology Assessment0
PP57 Collaborating In Times Of COVID: The Launch Of The National Wales COVID-19 Evidence Centre0
PP142 Time-Driven Activity-Based Costing (TDABC) Of Brazilian Public Healthcare System (SUS): Preliminary Results For Osteogenesis Imperfecta (OI)0
OP78 Taking A Societal Perspective In Health Technology Assessment: Is Environmental Impact A Special Case?0
PD56 Conceptual Issues In The Valuation Of Health States In Children0
PP61 Plugging the Gap of Fetoscopy in Congenital Diaphragmatic Hernia Pregnancies: Value for Money?0
PP95 Health Professionals’ Participation On Health Technology Assessment (HTA) Public Consultation: A Distribution Analysis Of Brazilian HTA In 20210
PP05 Effect Modifiers In Indirect Treatment Comparisons: Guidance Is Needed To Ensure An Unbiased Identification In Decision-Making0
OP82 Patient Involvement In Health Technology Assessment0
PD21 Data Sources And Real-World Data On Medical Devices In The Brazilian Scenario0
OP81 Do Sustainable Healthcare Principles Inform Guidance Development? An Exemplary Case Study In Respiratory Care0
OP54 The Early Detection And Warning System ‘SINTESIS-New Technologies’: A Horizon Scanning Experience In Spain0
PP23 A Health Technology Assessment Of Computerized Clinical Decision Support Systems: Challenges And Lessons Learnt0
PP108 Multidimensional Analysis Of Peristeen Plus Medical Device0
PP115 Analysis Of Previous Joint Clinical Assessment And Potential Transferability To Four European Countries: Case Study And Conceptual Approach0
PD32 Cost-Utility Of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres For Chemotherapy-Refractory Metastatic Colorectal Cancer In Brazil0
OP83 Joining Efforts To Improve Patient Involvement In Health Technology Assessment: The Case Of The RedETS Patient Interest Group0
PP79 Use Of Vagus Nerve Stimulation Therapy In Treatment-Resistant Depression0
PD02 A Literature Review Of Treatment Schemes And Effects For Beta Thalassemia In China0
OP02 The Use Of Discrete Choice Experiments For Measuring Patient Preferences In Health Technology Assessment0
PP151 VALIDATE Methodology On A Medication-Related Clinical Decision Support System: Holistic Assessment For Optimal Technology Adoption0
PP14 Value-Based Pricing For Advanced Therapy Medicinal Products: Emerging Affordability Solutions0
PD25 Use Of Real-World Evidence In The Reimbursement Assessment Of Medical Devices0
The role of quantitative bias analysis for nonrandomized comparisons in health technology assessment: recommendations from an expert workshop0
PP96 Joint Clinical Assessments – Implementation And Lessons For The Next Stage Of EU HTA0
OP27 Health Technology Assessment Processes, Characteristics, And Key Differences In High, Middle, And Low-Income Countries Of Asia Pacific Region0
PD08 A Systematic Review Of Reporting Quality Of Economic Evaluations In TCM In NRDL Of China Based On CHEERS0
PP155 Should Breast Cancer Patients Avoid Venipuncture In The Ipsilateral Arm? A Rapid Review Of The Evidence0
OP64 NICE Listens: Engaging The Public On How To Address Health Inequalities In Health Technology Assessment And Guideline Development0
OP63 Incorporating Machine Learning Methods In Health Economic Evaluations: A Case Study On Depression Prevention0
PD13 Methodologies In Economic Evaluations Of Biomarkers – A Systematic Review0
PP129 Usefulness, Acceptability And Satisfaction Of A Decision Making Tool For Clinical Meso-Management In Type 2 Diabetes Mellitus0
PP112 Reimbursement Decisions for Medical Services in Austria: An Analysis of Influencing Factors for the Hospital Individual Services Catalogue0
0.15024209022522